Mobile

Trial of Exemestane +/- MM-121 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive and/or Progesterone Receptor Positive Her2 Negative Breast Cancer

Mise à jour : Il y a 4 ans
Référence : NCT01151046

Femme Homme

Extrait

To determine whether the combination MM-121 + Exemestane in ER+ and/or PR+ breast cancer patients is more effective than Exemestane alone

Critère d'inclusion

  • Her2 Negative Breast Cancer Patients

Liens